Berobenatide (PF3944) is an investigational GLP-1 receptor agonist peptide that Pfizer is developing for chronic weight management and obesity-related comorbidities, with a program explicitly designed to support monthly maintenance dosing
Simple daily application works while clinical microneedling (like the 2025 Kuceki protocol) produces more dramatic results, a basic topical spray applied before bed still produces statistically significant hair growth over 6 months
Compounding a medicine using an active ingredient that is not contained in a product registered with SAHPRA is illegal, in terms of the requirements of the Medicines and Related Substances Act
Testing should include mass spectrometry confirmation of molecular identity, HPLC purity analysis, and bacterial endotoxin screening
Tracking methods like DEXA scans, bioelectrical impedance analysis, or progress photos help you see whether you are truly preserving muscle or losing it alongside fat